Compound Detail
CHEMBL1422
SITAGLIPTIN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1422 |
| Name | SITAGLIPTIN |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | MFFMDFFZMYYVKS-SECBINFHSA-N |
| Therapeutic | ✓ Yes |
9
Targets
111
Activities
3
Assay Types
30
PK Parameters
20
Publications
7
Known Names
20
Indications
Molecular Properties
407.3
MW (Da)
2.02
ALogP
5
HBA
1
HBD
77.0
PSA (Ų)
0.62
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2006 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Diabetes Mellitus Diabetes Mellitus, Type 2 Diabetic Foot Graft vs Host Disease Graft vs Host Disease Myocardial Infarction Renal Insufficiency, Chronic Severe Acute Respiratory Syndrome Carcinoma, Pancreatic Ductal Cystic Fibrosis Diabetes Mellitus, Type 1 Glucose Intolerance Glucose Intolerance HIV Infections Hyperlipidemias Non-alcoholic Fatty Liver Disease Non-alcoholic Fatty Liver Disease Obesity Polycystic Ovary Syndrome Prediabetic State
ATC Classification
A10BH01
sitagliptin
Level 1: ALIMENTARY TRACT AND METABOLISM
Level 2: DRUGS USED IN DIABETES
Activity Summary
IC50 106 meas. best 9.06
Kd 4 meas. best 8.28
Ki 1 meas. best 7.75
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Dipeptidyl peptidase 4 CHEMBL284 | IC50 | 9.06 | 7.753 | 0.9 | 61 |
| Dipeptidyl peptidase 4 CHEMBL284 | Kd | 8.28 | 7.9875 | 5.3 | 4 |
| Dipeptidyl peptidase 4 CHEMBL3883 | IC50 | 7.83 | 7.6233 | 14.7 | 3 |
| Dipeptidyl peptidase 4 CHEMBL284 | Ki | 7.75 | 7.75 | 18.0 | 1 |
| Dipeptidyl peptidase 4 CHEMBL4653 | IC50 | 7.48 | 7.48 | 33.0 | 1 |
| Dipeptidyl peptidase 8 CHEMBL4657 | IC50 | 5.74 | 4.4854 | 1820.0 | 13 |
| Dipeptidyl peptidase 9 CHEMBL4793 | IC50 | 5.51 | 4.37 | 3060.0 | 6 |
| Prolyl endopeptidase FAP CHEMBL4683 | IC50 | 5.23 | 4.6067 | 5830.0 | 3 |
| Angiotensin-converting enzyme CHEMBL1808 | IC50 | 4.96 | 4.96 | 11000.0 | 1 |
| Dipeptidyl peptidase IV CHEMBL4295559 | IC50 | 4.75 | 4.75 | 18000.0 | 1 |
| Dipeptidyl peptidase 2 CHEMBL3976 | IC50 | 4.22 | 4.22 | 59830.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 0.523 | uM.hr.Kg/mg | Rattus norvegicus |
| AUC | 1.0 | uM.hr.Kg/mg | Macaca mulatta |
| AUC | 8.3 | uM.hr.Kg/mg | Canis lupus familiaris |
| AUC | 0.523 | uM.hr.Kg/mg | Rattus norvegicus |
| AUC | 560.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 740.0 | ng.hr.mL-1 | Mus musculus |
| CL | 60.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 60.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 6.0 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 28.0 | mL.min-1.kg-1 | Macaca mulatta |
| CL | 60.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 6.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 1.3 | mL.min-1.kg-1 | Homo sapiens |
| CL | 6.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 6.0 | mL.min-1.kg-1 | Homo sapiens |
| Cmax | 330.0 | nM | Rattus norvegicus |
| Cmax | 761.07 | nM | Mus musculus |
| F | 76.0 | % | Rattus norvegicus |
| F | 76.0 | % | Rattus norvegicus |
| F | 100.0 | % | Canis lupus familiaris |
| F | 68.0 | % | Macaca mulatta |
| F | 76.0 | % | Rattus norvegicus |
| F | 75.7 | % | Mus musculus |
| F | 76.0 | % | Rattus norvegicus |
| Fu | 0.62 | - | Homo sapiens |
| Fu | 0.62 | - | Homo sapiens |
| MRT | 7.78 | hr | Homo sapiens |
| T1/2 | 1.7 | hr | Rattus norvegicus |
| T1/2 | 1.7 | hr | Rattus norvegicus |
| T1/2 | 4.9 | hr | Canis lupus familiaris |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine